UCM 765 is a melatonin MT(2) receptor partial agonist.
Uses
UCM765 is a selective MT2-type melatonin receptor ligand with hypnotic, analgesic and anxiolytic activities. The partial agonist effect of UCM765 has attracted attention in pharmacological studies. By structurally modifying UCM765, its water solubility and metabolic stability can be improved, thereby increasing its bioavailability. The biological activity of UCM765 has been verified in a rat model, supporting its potential for further pharmacological studies[1].
References
[1] N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability DOI:10.1002/cmdc.202100405